94 related articles for article (PubMed ID: 6381337)
1. Preliminary results on tolerance and toxicity tests using human fibroblast interferon (beta-type) in patients with herpes genitalis infections.
Emoedi G; Askenazy J; Suemeghy Z
Int J Clin Pharmacol Res; 1983; 3(4):275-8. PubMed ID: 6381337
[TBL] [Abstract][Full Text] [Related]
2. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
Bryson YJ; Dillon M; Lovett M; Acuna G; Taylor S; Cherry JD; Johnson BL; Wiesmeier E; Growdon W; Creagh-Kirk T; Keeney R
N Engl J Med; 1983 Apr; 308(16):916-21. PubMed ID: 6339923
[TBL] [Abstract][Full Text] [Related]
3. [Beta-interferon for labial and genital herpes virus infection].
Glezerman M; Lunenfeld E; Doerner T; Cohen V; Sarov I; Revel M
Harefuah; 1989 Jan; 116(2):88-90. PubMed ID: 2651244
[TBL] [Abstract][Full Text] [Related]
4. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
[TBL] [Abstract][Full Text] [Related]
5. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
[TBL] [Abstract][Full Text] [Related]
6. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
7. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
8. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
9. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA
J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417
[TBL] [Abstract][Full Text] [Related]
10. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis.
Lebwohl M; Sacks S; Conant M; Connor J; Douglas JM; Eron L; Marlowe S; Mendelson J; Chen V; Bradstreet P
Antiviral Res; 1992 Mar; 17(3):235-43. PubMed ID: 1567188
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects.
de Bruyn G; Vargas-Cortez M; Warren T; Tyring SK; Fife KH; Lalezari J; Brady RC; Shahmanesh M; Kinghorn G; Beutner KR; Patel R; Drehobl MA; Horner P; Kurtz TO; McDermott S; Wald A; Corey L
Vaccine; 2006 Feb; 24(7):914-20. PubMed ID: 16213066
[TBL] [Abstract][Full Text] [Related]
12. [Interferon in skin diseases].
Niimura M
Gan To Kagaku Ryoho; 1984 Feb; 11(2):221-6. PubMed ID: 6364993
[TBL] [Abstract][Full Text] [Related]
13. Interferon efficiency in the treatment of herpetic dermatites. I. A double-blind placebo controlled study.
Alecu M; Ghyka GR; Călugăru A; Coman G
Med Interne; 1989; 27(2):127-35. PubMed ID: 2683005
[TBL] [Abstract][Full Text] [Related]
14. Genital shedding of herpes simplex virus among men.
Wald A; Zeh J; Selke S; Warren T; Ashley R; Corey L
J Infect Dis; 2002 Oct; 186 Suppl 1():S34-9. PubMed ID: 12353185
[TBL] [Abstract][Full Text] [Related]
15. Topical interferon cream for the treatment of herpes genitalis: a double-blind controlled trial.
Batcheler LM; Bonham DG; Collins R; Liddell HS
Aust N Z J Obstet Gynaecol; 1986 Aug; 26(3):239-41. PubMed ID: 3028362
[TBL] [Abstract][Full Text] [Related]
16. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
[TBL] [Abstract][Full Text] [Related]
17. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
18. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
19. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
20. The effect of interferon in herpes simplex infections in man.
Armstrong JA
Tex Rep Biol Med; 1981-1982; 41():571-4. PubMed ID: 6189222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
